Yvonne Ceder
16 – 30 of 51
- show: 15
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
Acoustic Enrichment of Extracellular Vesicles from Biological Fluids
(
- Contribution to journal › Article
- 2017
-
Mark
Clinical-Scale Cell-Surface-Marker Independent Acoustic Microfluidic Enrichment of Tumor Cells from Blood
(
- Contribution to journal › Article
-
Mark
MicroRNAs as cancer therapeutics : A step closer to clinical application
(
- Contribution to journal › Scientific review
- 2016
-
Mark
The Potential of MicroRNAs as Prostate Cancer Biomarkers.
(
- Contribution to journal › Scientific review
-
Mark
Non-coding RNAs in Prostate Cancer: From Discovery to Clinical Applications.
(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
The Molecular Evolution of Castration-resistant Prostate Cancer
(
- Contribution to journal › Scientific review
- 2015
-
Mark
Myc-dependent purine biosynthesis affects nucleolar stress and therapy response in prostate cancer.
(
- Contribution to journal › Article
-
Mark
The Axl-Regulating Tumor Suppressor miR-34a Is Increased in ccRCC but Does Not Correlate with Axl mRNA or Axl Protein Levels.
(
- Contribution to journal › Article
-
Mark
MicroRNA-135b regulates ERα, AR and HIF1AN and affects breast and prostate cancer cell growth.
(
- Contribution to journal › Article
-
Mark
miR-145 suppress the androgen receptor in prostate cancer cells and correlates to prostate cancer prognosis.
(
- Contribution to journal › Article
-
Mark
miR-183 in Prostate Cancer Cells Positively Regulates Synthesis and Serum Levels of Prostate-specific Antigen.
(
- Contribution to journal › Article
-
Mark
Exosomal microRNAs as Potential Biomarkers in Castration-resistant Prostate Cancer.
(
- Contribution to journal › Debate/Note/Editorial
- 2014
-
Mark
Expression of miR-34c induces G2/M cell cycle arrest in breast cancer cells
(
- Contribution to journal › Article
- 2013
-
Mark
Upregulation of miR-96 Enhances Cellular Proliferation of Prostate Cancer Cells through FOXO1.
(
- Contribution to journal › Article
-
Mark
miR-205 negatively regulates the androgen receptor and is associated with adverse outcome of prostate cancer patients.
(
- Contribution to journal › Article